Annual Cash & Cash Equivalents
$183.58 M
+$75.63 M+70.05%
December 31, 2024
Summary
- As of March 12, 2025, KNSA annual cash & cash equivalents is $183.58 million, with the most recent change of +$75.63 million (+70.05%) on December 31, 2024.
- During the last 3 years, KNSA annual cash & cash equivalents has risen by +$61.11 million (+49.90%).
- KNSA annual cash & cash equivalents is now at all-time high.
Performance
KNSA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$183.58 M
+$86.20 M+88.53%
December 31, 2024
Summary
- As of March 12, 2025, KNSA quarterly cash and cash equivalents is $183.58 million, with the most recent change of +$86.20 million (+88.53%) on December 31, 2024.
- Over the past year, KNSA quarterly cash and cash equivalents has stayed the same.
- KNSA quarterly cash and cash equivalents is now -35.70% below its all-time high of $285.52 million, reached on June 30, 2018.
Performance
KNSA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
KNSA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +70.0% | 0.0% |
| 3 y3 years | +49.9% | +49.9% |
| 5 y5 years | +291.2% | +291.2% |
KNSA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +70.0% | at high | +189.9% |
| 5 y | 5-year | at high | +291.2% | -3.5% | +291.2% |
| alltime | all time | at high | +303.0% | -35.7% | +303.0% |
Kiniksa Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $183.58 M(+70.1%) | $183.58 M(+88.5%) |
| Sep 2024 | - | $97.38 M(-1.9%) |
| Jun 2024 | - | $99.27 M(-29.6%) |
| Mar 2024 | - | $141.08 M(+30.7%) |
| Dec 2023 | $107.95 M(-12.0%) | $107.95 M(-8.4%) |
| Sep 2023 | - | $117.83 M(+4.7%) |
| Jun 2023 | - | $112.57 M(+39.6%) |
| Mar 2023 | - | $80.62 M(-34.3%) |
| Dec 2022 | $122.72 M(+0.2%) | $122.72 M(-30.2%) |
| Sep 2022 | - | $175.76 M(+86.4%) |
| Jun 2022 | - | $94.31 M(+48.9%) |
| Mar 2022 | - | $63.32 M(-48.3%) |
| Dec 2021 | $122.47 M | $122.47 M(-35.6%) |
| Sep 2021 | - | $190.18 M(+13.2%) |
| Jun 2021 | - | $167.95 M(+40.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $119.86 M(+5.1%) |
| Dec 2020 | $114.04 M(+143.0%) | $114.04 M(+32.8%) |
| Sep 2020 | - | $85.87 M(-30.4%) |
| Jun 2020 | - | $123.46 M(+16.1%) |
| Mar 2020 | - | $106.34 M(+126.6%) |
| Dec 2019 | $46.93 M(-34.8%) | $46.93 M(-31.8%) |
| Sep 2019 | - | $68.81 M(-16.9%) |
| Jun 2019 | - | $82.81 M(+0.2%) |
| Mar 2019 | - | $82.63 M(+14.8%) |
| Dec 2018 | $71.98 M(+58.0%) | $71.98 M(+3.3%) |
| Sep 2018 | - | $69.66 M(-75.6%) |
| Jun 2018 | - | $285.52 M(+29.1%) |
| Mar 2018 | - | $221.11 M(+385.4%) |
| Dec 2017 | $45.55 M(-18.6%) | $45.55 M |
| Dec 2016 | $55.97 M | - |
FAQ
- What is Kiniksa Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Kiniksa Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Kiniksa Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of KNSA is $183.58 M
What is the all time high annual cash & cash equivalents for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual cash & cash equivalents is $183.58 M
What is Kiniksa Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, KNSA annual cash & cash equivalents has changed by +$75.63 M (+70.05%)
What is Kiniksa Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of KNSA is $183.58 M
What is the all time high quarterly cash and cash equivalents for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly cash and cash equivalents is $285.52 M
What is Kiniksa Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, KNSA quarterly cash and cash equivalents has changed by $0.00 (0.00%)